HEPSIN inhibits cell growth/invasion in prostate cancer cells.

Expression of HEPSIN, a type II transmembrane serine protease in prostate cancer (CaP), has been highlighted by several studies analyzing CaP-specific gene expression alterations by cDNA microarray. Evaluations of the biological functions of HEPSIN in CaP cells are warranted for better assessment of its utility as a biomarker and/or therapeutic target. In stable clones of PC-3/HEPSIN transfectants, there was a dramatic reduction in the cell growth, cell invasion, and soft agar colony formation. A higher proportion of PC-3/HEPSIN cells were in the G(2)-M phase of the cell cycle, and there was also an increase in the cell population undergoing apoptosis. Preliminary analysis of HEPSIN transfections into LNCaP and DU145 cells further revealed cell growth-inhibitory effects. These results underscore that exogenous HEPSIN expression negatively regulates cell growth in metastatic CaP cell lines. Although the cause of the biological consequence of HEPSIN overexpression in primary CaP remains to be determined, the negative cell growth-regulatory effects of HEPSIN in metastatic CaP cells reported here have unraveled possible cellular and molecular mechanisms underlying observations that link decreased/loss of HEPSIN expression with poor prognosis of CaP.

[1]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[2]  K. Kurachi,et al.  A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. , 1988, Biochemistry.

[3]  K. Kurachi,et al.  Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. , 1991, The Journal of biological chemistry.

[4]  K. Kurachi,et al.  Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Brooks,et al.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Weijerman,et al.  Characterization of adult human prostatic epithelial-cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective sv40-genome. , 1994, International journal of oncology.

[7]  M. Garnick,et al.  The dilemmas of prostate cancer. , 1994, Scientific American.

[8]  M. Webber,et al.  Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Kisiel,et al.  Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation (*) , 1995, The Journal of Biological Chemistry.

[10]  J. Rhim,et al.  Radiation-induced Neoplastic Transformation of Human Prostate Epithelial Cells' , 2006 .

[11]  M. Webber,et al.  Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. , 1997, Cancer research.

[12]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[13]  K. Shigemasa,et al.  Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. , 1997, Cancer research.

[14]  M. Halks-Miller,et al.  Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. , 1998, The Journal of clinical investigation.

[15]  W. Kisiel,et al.  Expression of the Factor VII Activating Protease, Hepsin, in situ in Renal Cell Carcinoma , 1998, Thrombosis and Haemostasis.

[16]  M K Brawer.  Prostate-specific antigen. , 2000, Seminars in surgical oncology.

[17]  H. Scher,et al.  Clinical states in prostate cancer: toward a dynamic model of disease progression. , 2000, Urology.

[18]  Shu-Wha Lin,et al.  Mice Deficient in Hepsin, a Serine Protease, Exhibit Normal Embryogenesis and Unchanged Hepatocyte Regeneration Ability , 2000, Thrombosis and Haemostasis.

[19]  D. Kelsell,et al.  Spotting prostate cancer. , 2001, Trends in molecular medicine.

[20]  Jeffrey A. Magee,et al.  Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.

[21]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[22]  Q. Wu.  Gene targeting in hemostasis. Hepsin. , 2001, Frontiers in bioscience : a journal and virtual library.

[23]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[24]  M. Bittner,et al.  Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.

[25]  N. Greenberg,et al.  Down‐regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer , 2001, The Prostate.

[26]  T. Stamey,et al.  Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.

[27]  Debashis Ghosh,et al.  alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.

[28]  E. Gelmann,et al.  Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Matthias Kretzler,et al.  Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.

[30]  J. Trent,et al.  α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .

[31]  J. Rhim,et al.  Cadmium-induced neoplastic transformation of human prostate epithelial cells. , 2002, International journal of oncology.

[32]  J. Moul,et al.  Molecular markers in prostate cancer: the role in preoperative staging. , 2002, Clinical prostate cancer.

[33]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[34]  V. Srikantan,et al.  Molecular Dissection of the Prostate Cancer Genome , 2003 .

[35]  L. Magnelli,et al.  Multiple pathways of cell invasion are regulated by multiple families of serine proteases , 2004, Clinical & Experimental Metastasis.